Stockscreener 앱 받기
2.53
0.78%
-0.02
Connect Biopharma Holdings Ltd 주식(CNTB)의 최신 뉴스
Analyzing Connect Biopharma (NASDAQ:CNTB) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives $8.50 Average Price Target from Analysts - Defense World
Connect Biopharma (NASDAQ:CNTB) Now Covered by Analysts at Lake Street Capital - MarketBeat
Check Out Connect Biopharma Holdings Ltd (CNTB)’s Trade Data Rather Than the Analysts’ Views - Setenews
Connect Biopharma (NASDAQ:CNTB) Research Coverage Started at Lake Street Capital - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Lake Street Initiates Coverage on Connect Biopharma (CNTB) with 'Buy' Rating | CNTB Stock News - GuruFocus
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - Daily Review Atlas
Shareholder Panacea Innovation Ltd Files To Sell 2,000,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Taking on analysts’ expectations and winning: Connect Biopharma Holdings Ltd (CNTB) - Setenews
Connect Biopharma Management to Participate in 8th Annual Evercore Healthcare Conference on December 2, 2025 - Quiver Quantitative
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - The Manila Times
Shareholder Zheng-Wu Family Trust Files To Sell 650,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Victorville Daily Press
Owner BioFortune Inc Files To Sell 500,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
HC Wainwright Issues Pessimistic Estimate for CNTB Earnings - Defense World
Connect Biopharma Reports Significant Loss Amid Development Efforts - TipRanks
Perhaps timely catching Lazydays Holdings Inc (GORV) would be a good idea - setenews.com
The time has not yet come to remove your chips from the table: Connect Biopharma Holdings Ltd (CNTB) - Setenews
FY2025 EPS Forecast for Connect Biopharma Lowered by Analyst - MarketBeat
Connect Biopharma’s (CNTB) “Buy” Rating Reiterated at BTIG Research - Defense World
Connect Biopharma's (CNTB) Buy Rating Reiterated at BTIG Research - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Announces Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
BTIG Reiterates Buy Rating for CNTB with $10 Price Target | CNTB Stock News - GuruFocus
Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView
[10-Q] Connect Biopharma Holdings Ltd Quarterly Earnings Report | CNTB SEC FilingForm 10-Q - Stock Titan
[8-K] Connect Biopharma Holdings Ltd Reports Material Event | CNTB SEC FilingForm 8-K - Stock Titan
Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN
Relmada Therapeutics Leads These 3 Promising Penny Stocks - Yahoo Finance
Terraphase Acquires Eolas Environmental - The Providence Journal
ADRs Advance; Connect Biopharma Holdings Ltd. Climbs 19% - 富途牛牛
Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential - Investing.com Canada
This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
0.82%
1.03%
자본화:
|
볼륨(24시간):